Ficha del valor · trimestre archivado
TERN
Terns Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Tenedores rastreados
0Δ titulares
30.56MAcciones mantenidas
$229.52MValor declarado
+0Nuevas posiciones
−0Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +1.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2026 | 105 | +14 | 70.88M | $3.72B | +22 | −9 |
| Q4 2025 | 91 | +4 | 71.76M | $2.90B | +5 | — |
| Q3 2025 | 16 | 0 | 30.56M | $229.52M | — | — |
| Q2 2025 | 13 | 0 | 20.60M | $76.83M | +2 | −2 |
| Q1 2025 | 10 | -3 | 10.19M | $28.12M | — | −3 |
| Q4 2024 | 13 | +2 | 13.10M | $72.60M | +2 | — |
| Q3 2024 | 10 | -1 | 11.63M | $97.00M | — | −1 |
| Q2 2024 | 11 | — | 7.84M | $53.39M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Morgan Stanley ✦ | 7.59M | — | $56.99M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 5.55M | +1.5% | $41.69M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | The Vanguard Group ✦ (pasivo) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | The Vanguard Group ✦ (pasivo) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | The Vanguard Group ✦ (pasivo) | 4.56M | +5.9% | $34.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 3.94M | +207.7% | $29.58M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Geode Capital Management ✦ (pasivo) | 1.71M | +5.0% | $12.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (pasivo) | 1.71M | +5.0% | $12.88M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (pasivo) | 1.61M | +16.9% | $12.06M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.59M | -59.2% | $11.94M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 1.37M | — | $10.25M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Millennium Management ✦ | 941.58K | -5.5% | $7.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 29 | Renaissance Technologies ✦ | 676.83K | -26.6% | $5.08M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Goldman Sachs Group ✦ | 546.83K | — | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 546.83K | — | $4.11M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 33 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 34 | Wellington Management ✦ | 253.41K | -24.4% | $1.90M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | T. Rowe Price ✦ | 94.17K | +18.4% | $708,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 60.35K | +2.4% | $453,231 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 60.35K | +2.4% | $453,231 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 40.18K | +8.7% | $301,782 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 34.03K | -83.4% | $255,565 | 0.0% | ▼ Trim | 6 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 314 tenedores, 121.84M acciones, $6.09B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API